Xanthogranulomatous pyelonephritis: a focus on microbiological and antibiotic resistance profiles
Open Access
- 7 April 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Urology
- Vol. 21 (1), 1-7
- https://doi.org/10.1186/s12894-021-00800-z
Abstract
Xanthogranulomatous pyelonephritis (XGP) is an inflammatory condition of the kidney and its treatment most often involves a combination of antibiotics and nephrectomy. This study aimed to define the clinical features and management of XGP, focusing on microbiological aspects and antibiotic therapy. We performed a retrospective study of 27 cases of XGP diagnosed between January 2001 and January 2020 to analyse their clinical and management characteristics. In addition, a literature review was conducted of XGP case series covering the period from 2000–2020. We searched PubMed for case series through April 2020 without language restrictions. Studies reporting case series of XGP (more than ten cases) were included if they were relevant to this study. Twenty-seven patients were diagnosed with XGP, and 26 of them were histologically proven to have XGP. A total of 81.5% of the patients were female and the mean age was 59.6 years (SD 19.2). The most frequent symptoms were flank pain (70.4%) and fever (59.3%), while 77.8% of patients had renal stones. Proteus mirabilis was detected in the urine culture in 18.5% of patients, followed by detection of Escherichia coli in 14.8% of patients. The computed tomography (CT) findings included perirenal (29.6%) or pararenal (29.6%) involvement in the majority of patients. Twenty-six patients underwent nephrectomy. Piperacillin/tazobactam and ceftriaxone were the most commonly prescribed antibiotics for treatment. The reported piperacillin/tazobactam and ceftriaxone resistance rates were 14.3% and 16.6%, respectively. Twenty-six case series were included in the literature review, reporting 693 cases in total. We found well-established characteristics of XGP patients among series in terms of previous history, clinical, laboratory and imaging findings, and operative and postoperative outcomes. It is important to know the clinical presentation and potential severity of XGP, as well as the most frequently involved microorganisms and their antibiotic resistance profiles, to select the most appropriate antibiotic therapy.Keywords
This publication has 44 references indexed in Scilit:
- Case of the Diffuse Form of Xanthogranulomatous PyelonephritisCase Reports in Urology, 2013
- Fluoroquinolone Resistance Among Gram-Negative Urinary Tract Patho-gens: Global Smart Program Results, 2009-2010The Open Microbiology Journal, 2012
- Xanthogranulomatous Pyelonephritis in Korean ChildrenYonsei Medical Journal, 2012
- Xanthogranulomatous pyelonephritis: presentation and management in the era of laparoscopyBJU International, 2009
- Laparoscopic Versus Open Radical Nephrectomy for Xanthogranulomatous Pyelonephritis: Contemporary Outcomes AnalysisJournal of Endourology, 2007
- Xanthogranulomatous Pyelonephritis: Analysis of 18 CasesAsian Journal of Surgery, 2006
- XANTHOGRANULOMATOUS PYELONEPHRITIS: OUR EXPERIENCE WITH REVIEW OF PUBLISHED REPORTSAnz Journal of Surgery, 2006
- Laparoscopic and Open Surgical Nephrectomy for Xanthogranulomatous PyelonephritisJournal of Endourology, 2005
- Xanthogranulomatous Pyelonephritis in Children: Diagnostic and Therapeutic AspectsEuropean Journal of Pediatric Surgery, 2002
- Sonographic features of xanthogranulomatous pyelonephritisJournal of Clinical Ultrasound, 2001